RARA CRAFT DATABASE for FDA Medical Devices
510(k)K222352

FDA DEVICE FACTS

Epildream HP 4000 MED

D.E.A Project S.R.1.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 27, 2023PRODUCT CODEGEX

Indications for use

EPILDREAM HP 4000 MED is indicated for: use in aesthetic, surgical and cosmetic applications and in selective treatments required in the medical specialties of dermatology and general and plastic surgery. 760 nm wavelength laser is indicated for : Hair removal, permanent hair reduction* 808 nm wavelength laser is indicated for : Hair removal, permanent hair reduction* 1060 nm wavelength laser is indicated for:

• Treatment of pseudofolliculitis barbae (PFB)

• Hair removal, permanent hair reduction* *Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regime. Use on all skin types (Fitzpatrick I-VI), including tanned skin. The handpiece which uses three wavelengths simultaneously is indicated for use in dermatology procedures requiring coagulation, and for the removal of benign vascular and vascular dependent lesions.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026